
1.16 Delayed Data As of Aug 12 | ![]() Today’s Change | 0.84 Today|||52-Week Range 4.44 | -67.96% Year-to-Date |
RVL Pharmaceuticals PLC (RVLP) Reports Q2 Loss, Tops Revenue Estimates Aug 11 / Zacks.com - Paid Partner Content | OncoCyte (OCX) Reports Q2 Loss, Misses Revenue Estimates Aug 10 / Zacks.com - Paid Partner Content |
Previous close | 1.20 |
Today’s open | 1.17 |
Day’s range | 1.16 - 1.18 |
Volume | 1,449 |
Average volume (3 months) | 102,075 |
Market cap | $23.4M |
Earnings growth (last year) | +87.29% |
Earnings growth (this year) | -294.74% |
Earnings growth (next 5 years) | +40.00% |
Revenue growth (last year) | +123.04% |
P/E ratio | NM |
Price/Sales | 0.87 |
Price/Book | 0.62 |
Next reporting date | August 15, 2022 |
EPS forecast (this quarter) | -$0.16 |
Annual revenue (last year) | $61.2M |
Annual profit (last year) | -$2.8M |
Net profit margin | -4.61% |
Sector Health Services |
Industry Medical/Nursing Services |
No executives to display |
Corporate headquarters San Diego, California |